companydata.dkcompanydata.dk

LICA PHARMACEUTICALS ApS: Financial statements 2014

CVR: 25332520

Source: annual report 2014, Danish Business Authority

01/01/2014 – 31/12/2014

LICA PHARMACEUTICALS ApS (CVR 25332520) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 269,406 and a net result of DKK 3,869,932 compared with DKK 782,891 the year before. That is a decrease of 21.1% compared with the year before. Equity in the 2014 report amounted to DKK 13,910,949. The solvency ratio was 99.8%.

Gross Profit
DKK 269,406
Profit/Loss
DKK 3,869,932
Equity
DKK 13,910,949
Total Assets
DKK 13,941,922

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014-269 t.3.9 mio.13.9 mio.-
2013-341 t.783 t.10 mio.-
2012468 t.296 t.953 t.9.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2014

LICA PHARMACEUTICALS ApS appoints new auditorOct 10, 2014

As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of LICA PHARMACEUTICALS ApS.

Auditor steps down at LICA PHARMACEUTICALS ApSOct 10, 2014

As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of LICA PHARMACEUTICALS ApS.

LICA PHARMACEUTICALS ApS: The 2013 annual report is outMay 31, 2014

LICA PHARMACEUTICALS ApS has published its annual report for 2013. Gross profit came to DKK 341,415, and the net result was DKK 782,891.

About LICA PHARMACEUTICALS ApS

LICA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LICA PHARMACEUTICALS A/S. The company has 1 employee (2013). In 2025, the company reported a gross profit of DKK 359,449 and a net result of DKK 450,710 compared with DKK 1,406,816 the year before. Equity in the 2025 report amounted to DKK 24,221,286.

Source: annual report 2025, Danish Business Authority